Senzime AB

6YC

Company Profile

  • Business description

    Senzime AB is a medical device company developing precision-based patient monitoring solutions for patients undergoing anesthesia. The company develops and markets precision-based monitoring systems for monitoring neuromuscular function and respiration during and after surgery, as well as for intensive care. Its product portfolio includes Next-generation TetraGraph, TetraGraph connectivity, TetraGraph for pediatric, Classic TetraGraph, and ExSpiron. The TetraGraph system is used in thousands of operating rooms internationally in university hospitals, public, private, military, and veterans hospitals. Senzime has direct sales resources in the USA and Germany and collaborates with distributors and licensees in its other main markets.

  • Contact

    Verkstadsgatan 8, hus 1
    Uppsala753 23
    SWE

    T: +46 18515640

    https://www.senzime.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    58

Stocks News & Analysis

stocks

Apple earnings: A smooth transition despite continued memory and supply headwinds

Shares fell as investors digested the latest earnings.
stocks

Two new ASX names added to our Global Best Stock Ideas

Our full global list includes 78 companies from around the world.
stocks

Big four bank holds up in weakening economic conditions

Major bank earnings hold up in challenging conditions.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,954.9054.00-0.60%
CAC 408,142.30121.991.52%
DAX 4026,246.74382.121.48%
Dow JONES (US)51,786.72197.26-0.38%
FTSE 10010,772.69134.261.26%
HKSE23,919.50393.531.67%
NASDAQ25,372.01207.650.83%
Nikkei 22562,188.63893.23-1.42%
NZX 50 Index13,783.4563.190.46%
S&P 5007,568.9227.520.36%
S&P/ASX 2008,834.5052.30-0.59%
SSE Composite Index3,686.1778.072.16%

Market Movers